University of California San Francisco
Give to UCSF
New genomic research led by UCSF scientists reveals that two common gene variants that lead to longer telomeres also significantly increase the risk of developing the deadly brain cancers known as gliomas.
UCSF won gold and silver medals in an international contest from the Council for Advancement and Support of Education (CASE), which announced its Circle of Excellence awards Wednesday morning.
Research led by a UCSF investigator establishes a new benchmark in the treatment of patients with metastatic colorectal cancer and sets a new expectation for how long patients can live with the particularly lethal disease.
From prostate cancer to immunotherapy to genetic testing, UCSF research is providing new insights and aiding in the development of new treatment strategies for cancer.
UCSF scientists have found that industry claims about e-cigarettes are unsupported by the evidence to date, including claims that they help smokers quit.
Deadly skin cancers in mice shrank in response to a new treatment that may complement other “immunotherapies” developed recently to boost the body’s own defenses against disease threats, according to a new study published by UCSF researchers.
Screening for cervical cancer has become more complex in the last few years, leaving physicians and patients in a quandary: do they test with the traditional Pap smear or do they add a test for human papilloma virus? UCSF ob/gyn Karen Smith-McCune, MD, PhD, weighs in.
Two from UCSF, Frank McCormick, PhD, FRS, and Jason G. Cyster, PhD, have been selected as members of the National Academy of Sciences, one of the highest honors that can be accorded an American scientist.
UCSF has been selected to join a national “dream team” on pancreatic cancer, part of a project designed to accelerate treatment and discoveries for one of the most deadly forms of cancer.
In an innovative clinical trial led by UCSF, the experimental drug neratinib along with standard chemotherapy was found to be a beneficial treatment for some women with newly diagnosed, high-risk breast cancer.
Doctors should focus on life expectancy when deciding whether to order mammograms for their oldest female patients, since the harms of screening likely outweigh the benefits unless women are expected to live at least another decade, according to a review of the scientific literature by experts at UCSF and Harvard medical schools.
The stiffening of breast tissue in breast-cancer development points to a new way to distinguish a type of breast cancer with a poor prognosis from a related, but often less deadly type, UCSF researchers have found in a new study.
One of the world’s preeminent cancer scientists, Alan Ashworth, PhD, FRS, has been appointed the new director of the UCSF Helen Diller Family Comprehensive Cancer Center.
A new UCSF study has shed light on the origins of one type of deadly pancreatic cancer, which could lead to more targeted and effective drug therapy.
The Clinical and Translational Science Institute at UCSF has entered into a three-year collaboration with MedImmune, the global biologics research and development arm of AstraZeneca, marking its first industry partnership for CTSI’s Catalyst Awards program’s therapeutic track.
CVS Caremark, the nation’s largest pharmacy health care company, and UCSF's Steven Schroeder say selling tobacco products is “clearly antithetical” to the role of pharmacies.
Researchers are harnessing the power of the body's natural defenses to fight deadly cancers, and the treatment appears to be powerful, effective and long-lasting.
New guidelines recommending screening mammography every two years for women ages 50 to 74 would save the United States $4.3 billion a year in health care costs, according to a UCSF-led study.
UCSF scientist Valerie Weaver, PhD, received a $1.2 million award from the California Institute for Regenerative Medicine (CIRM) for research that explores the transformation of stem cells into specialized cell types.
Scientists have discovered a type of RNA that could have enormous potential for better diagnosing and treating many types of cancer, Alzheimer's, multiple sclerosis and other diseases.
UCSF and Quest Diagnostics, the world's leading provider of diagnostic information services, have formed a collaboration to accelerate the translation of biomedical research into advanced diagnostics in the field of precision medicine.
Chancellor Susan Desmond-Hellman kicked off a special day-long symposium recognizing the winners of the 2014 Breakthrough Prizes in Life Sciences on Dec. 13. It was the centerpiece of a two-day celebration hosted by UCSF.
Experts across UCSF weigh in on what some of 2014's top trends are in research and patient care.
Some of the world's top researchers converged at UCSF as part of a two-day celebration of the 2014 Breakthrough Prize in Life Sciences, nicknamed the "Oscars of Science."
A team led by scientists from UCSF has discovered that recurrent gliomas may have genetic profiles that are markedly different from those of the initial tumors that spawned them.
The nation’s top scientists will gather at UCSF to discuss the latest in research discovery at a special symposium honoring the 2013 and 2014 Breakthrough Prize in Life Sciences Award recipients on Friday, Dec. 13.
